Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense
Authors
Keywords
Xeno-autosialylation, Cancer glycosylation, Cancer immunoediting, Sialoglycans, Altered branching, Tumor immunosuppression
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 72, Issue 7, Pages 1231-1248
Publisher
Springer Nature
Online
2014-12-08
DOI
10.1007/s00018-014-1799-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice
- (2014) Yukiko Tomioka et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sialic Acids Sweeten a Tumor's Life
- (2014) C. Bull et al. CANCER RESEARCH
- Glycans in immune recognition and response
- (2014) Ron Amon et al. CARBOHYDRATE RESEARCH
- Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance
- (2014) Camilla Jandus et al. JOURNAL OF CLINICAL INVESTIGATION
- Glycosylation-Dependent Interactions of C-Type Lectin DC-SIGN with Colorectal Tumor-Associated Lewis Glycans Impair the Function and Differentiation of Monocyte-Derived Dendritic Cells
- (2014) M. Nonaka et al. JOURNAL OF IMMUNOLOGY
- Knockdown of Mgat5 Inhibits Breast Cancer Cell Growth with Activation of CD4+ T Cells and Macrophages
- (2014) D. Li et al. JOURNAL OF IMMUNOLOGY
- Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody
- (2014) A. M. Hernandez et al. JOURNAL OF IMMUNOLOGY
- Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells
- (2014) Mylène A. Carrascal et al. Molecular Oncology
- Microbial glycan microarrays define key features of host-microbial interactions
- (2014) Sean R Stowell et al. Nature Chemical Biology
- Discovery of Specific Metastasis-Related N-Glycan Alterations in Epithelial Ovarian Cancer Based on Quantitative Glycomics
- (2014) Xingwang Zhang et al. PLoS One
- Selectins Mediate Small Cell Lung Cancer Systemic Metastasis
- (2014) Franziska Heidemann et al. PLoS One
- Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies
- (2014) O. M. T. Pearce et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Carbohydrate-Mimetic Peptides for Pan Anti-Tumor Responses
- (2014) Thomas Kieber-Emmons et al. Frontiers in Immunology
- Molecular Recognition of Gangliosides and Their Potential for Cancer Immunotherapies
- (2014) Ute Krengel et al. Frontiers in Immunology
- Altered Tumor-Cell Glycosylation Promotes Metastasis
- (2014) Irina Häuselmann et al. Frontiers in Oncology
- Metastatic Growth Progression Caused by PSGL-1-Mediated Recruitment of Monocytes to Metastatic Sites
- (2013) A. Hoos et al. CANCER RESEARCH
- Assessment of Sialic Acid Diversity in Cancer- and Non-Cancer Related CA125 Antigen Using Sialic Acid-Binding Ig-Like Lectins (Siglecs)
- (2013) N. Mitic et al. DISEASE MARKERS
- A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells
- (2013) Ana Victoria Casadesús et al. GLYCOCONJUGATE JOURNAL
- Binding of a Sialic Acid-recognizing Lectin Siglec-9 Modulates Adhesion Dynamics of Cancer Cells via Calpain-mediated Protein Degradation
- (2013) Ilhamjan Sabit et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Binding of the Sialic Acid-binding Lectin, Siglec-9, to the Membrane Mucin, MUC1, Induces Recruitment of β-Catenin and Subsequent Cell Growth
- (2013) Shuhei Tanida et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
- (2013) Jason E Hudak et al. Nature Chemical Biology
- Glyco-engineering 'super-self'
- (2013) Matthew S Macauley et al. Nature Chemical Biology
- Cell Death in Immune Thrombocytopenia: Novel Insights and Perspectives
- (2013) Stephan von Gunten et al. SEMINARS IN HEMATOLOGY
- Dendritic Cells: A Spot on Sialic Acid
- (2013) Hélio J. Crespo et al. Frontiers in Immunology
- CD33-related siglecs as potential modulators of inflammatory responses
- (2012) Paul R. Crocker et al. Annals of the New York Academy of Sciences
- Sulfated glycans control lymphocyte homing
- (2012) Hiroto Kawashima et al. Annals of the New York Academy of Sciences
- Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody
- (2012) Nobuyoshi Hayashi et al. CANCER SCIENCE
- The bisecting GlcNAc in cell growth control and tumor progression
- (2012) Hazuki E. Miwa et al. GLYCOCONJUGATE JOURNAL
- Sialidase significance for cancer progression
- (2012) Taeko Miyagi et al. GLYCOCONJUGATE JOURNAL
- Carbohydrate to carbohydrate interaction in development process and cancer progression
- (2012) Kazuko Handa et al. GLYCOCONJUGATE JOURNAL
- Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
- (2012) Gabriel A. Rabinovich et al. IMMUNITY
- Metabolism of Vertebrate Amino Sugars withN-Glycolyl Groups
- (2012) Kalyan Banda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Colonic Epithelial Cells Express Specific Ligands for Mucosal Macrophage Immunosuppressive Receptors Siglec-7 and -9
- (2012) K. Miyazaki et al. JOURNAL OF IMMUNOLOGY
- Metabolic Flux Increases Glycoprotein Sialylation: Implications for Cell Adhesion and Cancer Metastasis
- (2012) Ruben T. Almaraz et al. MOLECULAR & CELLULAR PROTEOMICS
- N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese
- (2012) Y Zhong et al. ORAL DISEASES
- Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions
- (2012) Takumi Kiwamoto et al. PHARMACOLOGY & THERAPEUTICS
- Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma
- (2012) Marta Osorio et al. Cancer Management and Research
- Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
- (2012) Valeria I. Segatori et al. Frontiers in Oncology
- Cell surface glycan–lectin interactions in tumor metastasis
- (2011) Neela D.S. Rambaruth et al. ACTA HISTOCHEMICA
- Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes
- (2011) A. Schaub et al. ALLERGY
- Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy
- (2011) Camilla Jandus et al. BIOCHEMICAL PHARMACOLOGY
- Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer
- (2011) K. Aalto et al. BLOOD
- Human Xeno-Autoantibodies against a Non-Human Sialic Acid Serve as Novel Serum Biomarkers and Immunotherapeutics in Cancer
- (2011) V. Padler-Karavani et al. CANCER RESEARCH
- A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
- (2011) Shigeru Tsuboi et al. EMBO JOURNAL
- Glycomic analysis of human mast cells, eosinophils and basophils
- (2011) S. J. North et al. GLYCOBIOLOGY
- Letter to the Glyco-Forum: Since there are PAMPs and DAMPs, there must be SAMPs? Glycan "self-associated molecular patterns" dampen innate immunity, but pathogens can mimic them
- (2011) A. Varki GLYCOBIOLOGY
- A Glycosphingolipid/Caveolin-1 Signaling Complex Inhibits Motility of Human Ovarian Carcinoma Cells
- (2011) Alessandro Prinetti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22
- (2011) Weihsu C. Chen et al. LEUKEMIA & LYMPHOMA
- Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9
- (2010) Mariko Ohta et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epigenetic Silencing of the Sulfate Transporter Gene DTDST Induces Sialyl Lewisx Expression and Accelerates Proliferation of Colon Cancer Cells
- (2010) A. Yusa et al. CANCER RESEARCH
- Glycomics Hits the Big Time
- (2010) Gerald W. Hart et al. CELL
- NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines
- (2010) Luis E. Fernandez et al. Clinical & Developmental Immunology
- Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells
- (2010) Y. Kawasaki et al. GLYCOBIOLOGY
- Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
- (2010) Huan Cao et al. IMMUNOLOGY
- Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses
- (2010) Satwinder Kaur Singh et al. INTERNATIONAL JOURNAL OF CANCER
- Emerging Role of α2,6-Sialic Acid as a Negative Regulator of Galectin Binding and Function
- (2010) Ya Zhuo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cell Death Modulation by Intravenous Immunoglobulin
- (2010) Stephan von Gunten et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Sialylation of 3-Methylcholanthrene-Induced Fibrosarcoma Determines Antitumor Immune Responses during Immunoediting
- (2010) M. Cohen et al. JOURNAL OF IMMUNOLOGY
- Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
- (2010) Jennifer A. Belisle et al. Molecular Cancer
- The Sialome—Far More Than the Sum of Its Parts
- (2010) Miriam Cohen et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Selectins promote tumor metastasis
- (2010) Heinz Läubli et al. SEMINARS IN CANCER BIOLOGY
- Basic and Clinical Immunology of Siglecs
- (2009) Stephan von Gunten et al. Annals of the New York Academy of Sciences
- Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate
- (2009) E. Kivi et al. BLOOD
- Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis
- (2009) J. Kisucka et al. BLOOD
- Platelet-Derived Transforming Growth Factor- Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
- (2009) H.-G. Kopp et al. CANCER RESEARCH
- Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: Clues in the ongoing search for new tumor markers
- (2009) Reiji Kannagi et al. CANCER SCIENCE
- Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy
- (2009) Mayrel Labrada et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Altered sphingolipid metabolism induced by tumor hypoxia - New vistas in glycolipid tumor markers
- (2009) Jun Yin et al. FEBS LETTERS
- Siglec-7 mediates nonapoptotic cell death independently of its immunoreceptor tyrosine-based inhibitory motifs in monocytic cell line U937
- (2009) Motoaki Mitsuki et al. GLYCOBIOLOGY
- GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells
- (2009) A. Prinetti et al. GLYCOBIOLOGY
- Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass
- (2009) Stephan von Gunten et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines
- (2009) Mariano R Gabri et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses
- (2009) G.-Y. Chen et al. SCIENCE
- DIFFERENT PATTERNS OF SIGLEC-9-MEDIATED NEUTROPHIL DEATH RESPONSES IN SEPTIC SHOCK
- (2009) Stephan von Gunten et al. SHOCK
- Siglecs as targets for therapy in immune-cell-mediated disease
- (2009) Mary K. O’Reilly et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Down-modulation of B cell signal transduction by ligation of mucins to CD22
- (2008) Munetoyo Toda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells
- (2008) Munetoyo Toda et al. BIOCHEMICAL JOURNAL
- Siglecs as positive and negative regulators of the immune system: Figure 1
- (2008) Paul R. Crocker et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Glycosylation diseases: Quo vadis?
- (2008) Harry Schachter et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
- (2008) C. Ay et al. BLOOD
- Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc
- (2008) T. Ju et al. CANCER RESEARCH
- Functional roles of N-glycans in cell signaling and cell adhesion in cancer
- (2008) Yan-Yang Zhao et al. CANCER SCIENCE
- Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3
- (2008) C Tringali et al. CELL DEATH AND DIFFERENTIATION
- Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease
- (2008) V. Padler-Karavani et al. GLYCOBIOLOGY
- Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function
- (2008) J. de Leon et al. INTERNATIONAL IMMUNOLOGY
- Protein-glycan interactions in the control of innate and adaptive immune responses
- (2008) Yvette van Kooyk et al. NATURE IMMUNOLOGY
- Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression
- (2008) M. Hedlund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started